Inventor · disambiguated record
Andrew Stephens
Also filed as: STEPHENS ANDREW · STEPHENS ANDREW N · STEPHENS ANDREW NICHOLAS
13 granted patents·7 pending applications·1,314 citations·filing 1995–2023
94Inventor score
Files withNEXSTAR PHARMACEUTICALS INC8RMW CHO GROUP LTD4GILEAD SCIENCES INC3HUDSON INST MED RES3FRIEBE MATTHIAS1
Top patents by PatentIndex Score
20 records- 0197US6737236B1Bioconjugation of macromoleculesPROLIGO LLC·Filed 1998·Granted May 18, 2004·376 cites·19 claims
- 0293US5789157ASystematic evolution of ligands by exponential enrichment: tissue selexNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Aug 4, 1998·154 cites·11 claims
- 0393US5712375ASystematic evolution of ligands by exponential enrichment: tissue selexNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Jan 27, 1998·156 cites·7 claims
- 0492US6127119ANucleic acid ligands of tissue targetNEXSTAR PHARMACEUTICALS INC·Filed 1997·Granted Oct 3, 2000·145 cites·21 claims
- 0590US5864026ASystematic evolution of ligands by exponential enrichment: tissue selexNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Jan 26, 1999·162 cites·22 claims
- 0687US5688935ANucleic acid ligands of tissue targetNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Nov 18, 1997·92 cites·13 claims
- 0780US6114120ASystematic evolution of ligands by exponential enrichment: tissue selexNEXSTAR PHARMACEUTICALS INC·Filed 1996·Granted Sep 5, 2000·78 cites·10 claims
- 0879US5763566ASystematic evolution of ligands by exponential enrichment: tissue SELEXNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Jun 9, 1998·75 cites·5 claims
- 0978US5750342ANucleic acid ligands of tissue targetNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted May 12, 1998·53 cites·7 claims
- 1076US7094535B2Nucleic acid ligands to integrinsGILEAD SCIENCES INC·Filed 2001·Granted Aug 22, 2006·4 cites·2 claims
- 1167US12384838B2CXCL10 binding proteins and uses thereofHUDSON INST MED RES·Filed 2023·Granted Aug 12, 2025·0 cites·5 claims
- 1266US6331394B1Nucleic acid ligands to integrinsGILEAD SCIENCES INC·Filed 1999·Granted Dec 18, 2001·19 cites·19 claims
- 1360US2025177533A1Photodynamic therapy and diagnosisRMW CHO GROUP LTD·Filed 2022·Application pending·0 cites
- 1460US2025127898A1Photodynamic therapy and diagnosisRMW CHO GROUP LTD·Filed 2022·Application pending·0 cites
- 1560US2025115633A1Photodynamic therapy and diagnosisRMW CHO GROUP LTD·Filed 2022·Application pending·0 cites
- 1659US2023365577A1Photodynamic Therapy and DiagnosisRMW CHO GROUP LTD·Filed 2023·Application pending·0 cites
- 1756US11725048B2CXCL10 binding proteins and compositions thereofHUDSON INST MED RES·Filed 2020·Granted Aug 15, 2023·0 cites·4 claims
- 1851US2007010473A1Nucleic acid ligands to integrinsGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 1949US2022127341A1A method for the treatment or prophylaxis of cancer by targeting the extracellular portion of keratin 14 (krt14) residing on cancer cellsHUDSON INST MED RES·Filed 2020·Application pending·0 cites
- 2042US2008207523A1Compounds as aptamer-dimers and their uses in diagnosis and therapyFRIEBE MATTHIAS·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Stephens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →